Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4f08 | 1RS | Tyrosine-protein kinase JAK2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 1.000 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.610 | |
| 3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.572 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.569 | |
| 4ehz | JAK | Tyrosine-protein kinase JAK1 | / | 0.568 | |
| 4e6d | 0NU | Tyrosine-protein kinase JAK2 | / | 0.563 | |
| 4i5c | C5I | Tyrosine-protein kinase JAK1 | / | 0.560 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.542 | |
| 4fk6 | 0UJ | Tyrosine-protein kinase JAK1 | / | 0.534 | |
| 4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.522 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.517 | |
| 4e4n | 0NL | Tyrosine-protein kinase JAK1 | / | 0.513 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.501 | |
| 4e6q | 0NV | Tyrosine-protein kinase JAK2 | / | 0.500 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.497 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.495 | |
| 4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.492 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.477 | |
| 3qxp | X64 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
| 2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
| 4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.467 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.463 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.462 | |
| 3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.459 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.452 | |
| 3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.445 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 2yaa | ATP | Death-associated protein kinase 2 | / | 0.444 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.442 | |
| 3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.442 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.441 | |
| 3eb0 | DRK | Uncharacterized protein | / | 0.441 | |
| 4e5w | 0NT | Tyrosine-protein kinase JAK1 | / | 0.441 | |
| 4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 |